Nuclear Export of Phosphorylated Galectin-3 Regulates Its Antiapoptotic Activity in Response to Chemotherapeutic Drugs

REFERENCES

• Akahani, S., Makker P. N., Inohara H., Kim H. R., and Raz A.. 1997. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res. 57:5272–5276.
   PubMed Web of Science ®Google Scholar
• Akari, H., Bour S., Kao S., Adachi A., and Strebel K.. 2001. The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J. Exp. Med. 194:1299–1311.
   PubMed Web of Science ®Google Scholar
• Alavi, A., Hood J. D., Frausto R., Stupack D. G., and Cheresh D. A.. 2003. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301:94–96.
   PubMed Web of Science ®Google Scholar
• Amit, S., Hatzubai A., Birman Y., Andersen J. S., Ben-Shushan E., Mann M., Ben-Neriah Y., and Alkalay I.. 2002. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 16:1066–1076.
   PubMed Web of Science ®Google Scholar
• Barondes, S. H., Cooper D. N., Gitt M. A., and Leffler H.. 1994 Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 269:20807–20810.
   PubMed Web of Science ®Google Scholar
• Bernerd, F., Sarasin A., and Magnaldo T.. 1999. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc. Natl. Acad. Sci. USA 96:11329–11334.
   PubMed Web of Science ®Google Scholar
• Biggs W. H., III, Meisenhelder J., Hunter T., Cavenee W. K., and Arden K. C.. 1999. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA 96:7421–7426.
   PubMed Web of Science ®Google Scholar
• Blagosklonny, M. V., Giannakakou P., el- Deiry W. S., Kingston D. G. I., Higgs P. I., Neckers L., and Fojo T.. 1997. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res. 57:130–135.
   PubMed Web of Science ®Google Scholar
• Blenis, J. 2001. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ. 12:397–408
   PubMedGoogle Scholar
• Cowles, E. A., Agrwal N., Anderson R. L., and Wang J. L.. 1990. Carbohydrate-binding protein 35. Isoelectric points of the polypeptide and a phosphorylated derivative. J. Biol. Chem. 265:17706–17712.
   PubMed Web of Science ®Google Scholar
• Danguy, A., Camby I., and Kiss R.. 2002. Galectins and cancer. Biochim. Biophys. Acta 1572:285–293.
   PubMed Web of Science ®Google Scholar
• Davidson, P. J., Davis M. J., Patterson R. J., Ripoche M. A., Poirier F., and Wang J. L.. 2002. Shuttling of galectin-3 between the nucleus and cytoplasm. Glycobiology 12:329–337.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., Martin P. L., Shastry B. S., and Roeder R. G.. 1983. Eukaryotic gene transcription with purified components. Methods Enzymol. 101:582–598.
   PubMed Web of Science ®Google Scholar
• Dominguez, D., Montserrat-Sentis B., Virgos-Soler A., Guaita S., Grueso J., Porta M., Puig I., Baulida J., Franci C., and Garcia de Herreros A.. 2003. Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. Mol. Cell. Biol. 23:5078–5089.
   PubMedGoogle Scholar
• Fan, M., and Chambers T. C.. 2001. Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy. Drug Resist. Update 4:253–267.
   PubMed Web of Science ®Google Scholar
• Ghose, A., Fleming J., El-Bayoumy K., and Harrison P. R.. 2001. Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways. Cancer Res. 61:7479–7487.
   PubMed Web of Science ®Google Scholar
• Gong, H. C., Honjo Y., Makker P. N., Hogan V., Mazurak N., Bresalier R. S., and Raz A.. 1999. The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res. 59:6239–6245.
   PubMed Web of Science ®Google Scholar
• Gross, S. D., and Anderson R. A.. 1998. Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. Cell Signaling 10:699–711.
   PubMed Web of Science ®Google Scholar
• Haldar, S., Basu A., and Croce C. M.. 1998. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res. 58:1609–1615.
   PubMed Web of Science ®Google Scholar
• Herrmann, J., Turck C. W., Atchison R. E., Huflejt M. E., Poulter L., Gitt M. A., Burlingame A. L., Barondes S. H., and Leffler H.. 1993. Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous proline-, glycine-, tyrosine-rich sequence with bacterial and tissue collagenase. J. Biol. Chem. 268:26704–26711.
   PubMedGoogle Scholar
• Ho, Y., Mason S., Kobayashi R., Hoekstra M., and Andrews B.. 1997. Role of the casein kinase I isoform, Hrr25, and the cell cycle-regulatory transcription factor, SBF, in the transcriptional response to DNA damage in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 94:581–586.
   PubMed Web of Science ®Google Scholar
• Honjo, Y., Inohara H., Akahani T., Yoshii S., Takenaka Y., Yoshida J., Hattori K., Tomiyama Y., Raz A., and Kubo T.. 2000. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin. Cancer Res. 6:4635–4640.
   PubMedGoogle Scholar
• Hsu, D. K., Yang R. Y., Pan Z., Yu L., Salomon D. R., Fung Leung W. P., and Liu F. T.. 2000. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 156:1073–1083.
   PubMed Web of Science ®Google Scholar
• Hubert, M., Wang S. Y., Wang J. L., Seve A. P., and Hubert J.. 1995. Intranuclear distribution of galectin-3 in mouse 3T3 fibroblasts: comparative analyses by immunofluorescence and immunoelectron. Exp. Cell Res. 220:397–406.
   PubMedGoogle Scholar
• Huflejt, M. E., Turck C. W., Lindstedt R., Barondes S. H., and Leffler H.. 1993. L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. J. Biol. Chem. 268:26712–26718.
   PubMedGoogle Scholar
• Ito, T., Deng X., Carr B., and May W. S.. 1997. Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 272:11671–11673.
   PubMed Web of Science ®Google Scholar
• Johnson, R., Spiegelman B., Hanahan D., and Wisdom R.. 1996. Cellular transformation and malignancy induced by ras require c-jun. Mol. Cell. Biol. 16:4504–4511.
   PubMed Web of Science ®Google Scholar
• Kageshita, T., Kashio Y., Yamauchi A., Seki M., Abedin M. J., Nishi N., Shoji H., Nakamura T., Ono T., and Hirashima M.. 2002. Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int. J. Cancer 99:809–816.
   PubMed Web of Science ®Google Scholar
• Kim, H. R., Lin H. M., Biliran H., and Raz A.. 1999. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res. 59:4148–4154.
   PubMed Web of Science ®Google Scholar
• Kuwabara, I., Kuwabara Y., Yang R. Y., Schuler M., Green D. R., Zuraw B. L., Hsu D. K., and Liu F. T.. 2001. Galectin-7 (PIG1:p53-induced gene 1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release J. Biol. Chem. 277:3487–3497.
   PubMedGoogle Scholar
• Lin, H. M., Moon B. K., Yu F., and Kim H. R.. 2000. Galectin-3 mediates genistein-induced G(2)/M arrest and inhibits apoptosis. Carcinogenesis 21:1941–1945.
   PubMedGoogle Scholar
• Liu, F. T., Patterson R. J., and Wang J. L.. 2002. Intracellular functions of galectins. Biochim. Biophys. Acta 1572:263–273.
   PubMed Web of Science ®Google Scholar
• Lotz, M. M., Andrews C. W., Korzelius C. A., Lee E. C., Steele G. D., Clarke A., and Mercurio A. M.. 1993. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic. Proc. Natl. Acad. Sci. USA 90:3466–3470.
   PubMed Web of Science ®Google Scholar
• Mazurek, N., Conklin J., Byrd J. C., Raz A., and Bresalier R. S.. 2000. Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J. Biol. Chem. 275:36311–36315.
   PubMedGoogle Scholar
• Moon, B. K., Lee Y. J., Battle P., Jessup J. M., Raz A., and Kim H. R. C.. 2001. Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis. Am. J. Pathol. 159:1055–1060.
   PubMedGoogle Scholar
• Mow, B. M., Blajeski A. L., Chandra J., and Kaufmann S. H.. 2001. Apoptosis and the response to anticancer therapy. Curr. Opin. Oncol. 13:453–462.
   PubMed Web of Science ®Google Scholar
• New, L., Jiang Y., and Han J.. 2003. Regulation of PRAK subcellular location by p38 MAP kinases. Mol. Biol. Cell 14:2603–2616.
   PubMedGoogle Scholar
• Ojala, P. M., Yamamoto K., Castanos-Velez E., Biberfeld P., Korsmeyer S. J., and Makela T. P.. 2000. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat. Cell Biol. 11:819–825.
   Google Scholar
• Openo, K. P., Kadrofske M. M., Patterson R. J., and Wang J. L.. 2000. Galectin-3 expression and subcellular localization in senescent human fibroblasts. Exp. Cell Res. 255:278–290.
   PubMedGoogle Scholar
• Park, J. W., Voss P. G., Grabski S., Wang J. L., and Patterson R. J.. 2001 Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein. Nucleic Acids Res. 29:3595–3602.
   PubMed Web of Science ®Google Scholar
• Pastorino, J. G., Tafani M., and Farber J. L.. 1999. Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway. J. Biol. Chem. 274:19411–19416.
   PubMed Web of Science ®Google Scholar
• Paz, A., Haklai R., Elad-Sfadia G., Ballan E., and Kloog Y.. 2001. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 20:7486–7493.
   PubMed Web of Science ®Google Scholar
• Perillo, N. L., Pace K. E., Seilhamer J. J., and Baum L. G.. 1995. Apoptosis of T cells mediated by galectin-1. Nature 378:736–739.
   PubMed Web of Science ®Google Scholar
• Pratesi, G., Perego P., and Zunino F.. 2001. Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapy. Biochem. Pharmacol. 61:381–386.
   PubMedGoogle Scholar
• Pruitt, K., Pruitt W. M., Bilter G. K., Westwick J. K., and Der C. J.. 2002. Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation. J. Biol. Chem. 277:31808–31817.
   PubMed Web of Science ®Google Scholar
• Rice, P. L., Goldberg R. J., Ray E. C., Driggers L. J., and Ahnen D. J.. 2001. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Cancer Res. 61:1541–1547.
   PubMed Web of Science ®Google Scholar
• Ruvolo, P. P., Deng X., Carr B. K., and May W. S.. 1998. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. 273:25436–25442.
   PubMed Web of Science ®Google Scholar
• Salah-Eldin, A. E., Inoue S., Tsukamoto S., Aoi H., and Tsuda M.. 2003. An association of Bcl-2 phosphorylation and Bax localization with their functions after hyperthermia and paclitaxel treatment. Int. J. Cancer 103:53–60.
   PubMed Web of Science ®Google Scholar
• Schreiher, M., Kolbus A., Piu F., Szabowski A., Mohle-Steinlein U., Tian J., Karin M., Angel P., and Wagner E. F.. 1999. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13:607–619.
   PubMedGoogle Scholar
• Srivastava, R. K., Srivastava A. R., Korsmeyer S. J., Nesterova M., Cho-Chung Y. S., and Longo D. L.. 1998. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 18:3509–3517.
   PubMed Web of Science ®Google Scholar
• Tsay, Y. G., Lin N. Y., Voss P. G., Patterson R. J., and Wang J. L.. 1999. Export of galectin-3 from nuclei of digitonin-permeabilized mouse 3T3 fibroblasts. Exp. Cell Res. 252:250–261.
   PubMed Web of Science ®Google Scholar
• Tsujimoto, Y., and Shimizu S.. 2000. Bcl-2 family: life-or-death switch. FEBS Lett. 466:6–10.
   PubMed Web of Science ®Google Scholar
• Van den Brule, F. A., Waltregny D., Liu F. T., and Castronovo V.. 2000. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int. J. Cancer 89:361–367.
   PubMed Web of Science ®Google Scholar
• Wang, H. G., Rapp U. R., and Reed J. C.. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629–638.
   PubMed Web of Science ®Google Scholar
• Wisdom, R., Johnson R. S., and Moore C.. 1999. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18:188–197.
   PubMed Web of Science ®Google Scholar
• Yamamoto, K., Ichijo H., and Korsmeyer S.. 1999. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell. Biol. 19:8469–8478.
   PubMed Web of Science ®Google Scholar
• Yang, R. Y., Hsu D. K., and Liu F. T.. 1996. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc. Natl. Acad. Sci. USA 93:6737–6742.
   PubMed Web of Science ®Google Scholar
• Yang, R. Y., and Liu F. T.. 2003. Galectins in cell growth and apoptosis. Cell Mol. Life Sci. 60:267–276.
   PubMed Web of Science ®Google Scholar
• Yin, X. M., Oltvai Z. N., and Korsmeyer S. J.. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321–323.
   PubMed Web of Science ®Google Scholar
• Yokote, H., Terada T., Matsumoto H., Kakishita K., Kinoshita Y., Nakao N., Nakai K., and Itakura T.. 2000. Dephosphorylation-induced decrease of anti-apoptotic function of Bcl-2 in neuronally differentiated P19 cells following ischemic insults. Brain Res. 857:78–86.
   PubMedGoogle Scholar
• Yoshii, T., Fukumori T., Honjo Y., Inohara H., Kim H. R. C., and Raz A.. 2002. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J. Biol. Chem. 277:6852–6857.
   PubMed Web of Science ®Google Scholar
• Yu, F., Finley R. L., Raz A., and Kim H. R. C.. 2002. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J. Biol. Chem. 277:15819–15827.
   PubMed Web of Science ®Google Scholar